PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study. (Record no. 30898126)

MARC details
000 -LEADER
fixed length control field 01567 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518100618.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202108s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1933-2874
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.jacl.2020.03.001
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Daniels, Stephen
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210806
245 00 - TITLE STATEMENT
Title PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical lipidology
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 322-330.e5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anticholesteremic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heterozygote
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperlipoproteinemia Type II
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element PCSK9 Inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Caprio, Sonia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chaudhari, Umesh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Manvelian, Garen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Baccara-Dinet, Marie T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brunet, Aurelie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Scemama, Michel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Loizeau, Virginie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bruckert, Eric
773 0# - HOST ITEM ENTRY
Title Journal of clinical lipidology
Related parts vol. 14
-- no. 3
-- p. 322-330.e5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.jacl.2020.03.001">https://doi.org/10.1016/j.jacl.2020.03.001</a>
Public note Available from publisher's website

No items available.